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Abstract 
Biomaterial-associated infection is a serious complication of modern implantation surgery. 
Thus, the improvement of implant surfaces is required to avoid the first stage for biofilm 
formation, bacterial adhesion. The current research addresses this issue by developing drug 
delivery systems (DDS) consisting of antibiotic-loaded polyhydroxyalkanoates (PHAs) 
coatings on titanium implants. Dip-coating technique was used to achieve optimal coatings 
with biodegradable biopolyesters, polyhydroxybutyrate (PHB) and its copolymer, 
polyhydroxybutyrate-co-hydroxyvalerate (PHBV). The coatings were completely 
characterized (wettability, topography, thickness and roughness), and studies of drug 
delivery, toxicity, antibacterial effect, and cell adhesion were performed. For both of 
biopolymers, surfaces were partially covered with 1 and 3 immersions, while with 6, they 
were completely covered. Although both antibiotic-loaded biopolymer coatings assure the 
protection against bacteria populations, PHBV coatings are closer to the desired release 
profile; its faster degradation provides for a greater and more stable drug release for a given 
period of time compared to PHB coatings. The use of coatings with different drug 
concentration per layer results in more controlled and homogeneous releases. The DDS 
designed not only assure toavoid the first stage of bacterial adhesion, but also their 
proliferation and biofilm formation, since the coatings degrade with time under physiological 
conditions, guaranteeing a prolonged drug release. 
 
Keywords: Drug delivery systems, biodegradable biopolymers, gentamicin, dip-coating 
technique, polyhydroxyalkanoates 
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1. INTRODUCTION 
Biomaterial-associated infection is a serious complication of modern implantation 
surgery which often leads to prolonged patient pain and functional losses. The removal 
of an infected implant is the final outcome of most of these infections, generating high 
costs for the health-care system and discomfort for the patient. Biomaterial infections are 
developed on the implant surface due to the ability of microorganisms to get attached 
and to further form biofilms [1]. Therefore, the study and the improvement of the implant 
surface to avoid the first stage for the biofilm formation of the pathogenic microorganism 
is required. To overcome implant-related infection and bacterial load on the implant 
surface, antibiotic drug incorporation and its controlled release can be a promising 
strategy. Implantable drug-eluting devices (or implantable drug delivery systems-DDS) 
offer several advantages over conventional drug delivery methods. For instance, they 
can provide localized, site-specific drug delivery, which is especially important in 
applications such as cardiology and oncology, where targeted delivery can improve the 
effectiveness of treatment and minimize side effects or damage to healthy tissue [2]. The 
design of DDS highly relies on polymers, which is driven by the suitability of 
physicochemical, mechanical and processability of the polymer-based formulations [3]. 
Synthetic polyesters, poly(lactic acid) (PLA), poly(glycolic acid) (PGA) and their 
copolymers, polycaprolactone (PCL), poly(lactic–co-glycolic acid) (PLGA) are 
examples of biodegradable polymers used for DDS [4,5]. Lately, natural polyesters 
polyhydroxyalkanoates (PHAs) emerged as a vast family of potential candidates as 
biodegradable polymers for DDS. Polyhydroxybutyrate (PHB) and i t s  copolymer  
Poly(3-hydroxyvalerate) (PHBV) which is less crystalline, and more flexible than PHB itself 
[6], are members of this family of biopolymers. PHAs are primarily characterized by the 
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fact that they are produced by microorganisms from removable resources, and, therefore, 
they exhibit superior traits with respect to synthetic polymers such as the prevention of toxic 
products from chemical polymerization [7]. Furthermore, the by-products of their 
hydrolytic degradation make it possible to obtain common blood constituents (a ketone 
body produced by the liver from fatty acids, ketogenesis) [8]. Pas have performed well 
in a number drug delivery applications due to their excellent biocompatibility, non-toxicity 
and biodegradability [3,9,10,11,12,13]. Metal-based drug eluting systems have received 
little attention in the literature in comparison to polymer-based systems. So far, only 
intramedullary nails with a PDLLA coating containing gentamicin were placed on the 
market [14]. For example, metal implants such as plates and wires have been coated with 
a polymer matrix layer loaded with a microbial antibiotic, while others have studied 
different therapeutic agents including triclosan and chlorhexidine (CHX) [15,16,17]. In 
such studies, however, in vitro antibiotic release experiments showed that most of the 
drug was released within several hours after exposure to an aqueous environment. Even 
in the most favorable case, the system was only able to provide the desired drug release 
for less than 12 days [18,19]. Therefore, long-term release drug delivery systems are 
required. In this research, we develop and study novel gentamicin-loaded PHAs 
coatings on titanium implants designed to serve as devices to prevent implant-
associated infections by a gentamicin-controlled release phase. We pay special attention 
to maintaining suitable concentrations of antibiotics for long periods of time, since it is 
essential for treating highly resistant infections. 
 
2. MATERIAL AND METHODS 
2.1 . Materials 
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Titanium bar was obtained from c.p. grade 2 Ti provided by Technaloy S.A. The bar was 
cut into disks that were 3 mm thick and 10 mm in diameter. PHB and PHBV were kindly 
provided by Dr. Martin Koller (Institute of Biotechnology and Biochemical Engineering-
Graz University of Technology). These PHAs were biosynthesized by Cupriavidus 
necator and glucose was the main carbon source used in their fermentations. The used 
antibiotic was gentamicin sulfate (Genta; C21H43N5O7, MW 477.596 g/mol, freely 
soluble in water), which was purchased by Sigma-Aldrich. Chemical products such as 
hydrogen peroxide, Trichloromethane (TCM), poly(vinyl alcohol) (PVA) were 
purchased from Sigma Chemical Co. and used without further purification. 
2.2. Biopolymer Characterization 
The molecular masses of the biopolymers were analyzed via gel performance 
chromatography (GPC). Chloroform was utilized as an eluent at a flow rate of 0.80 ml 
min-1 with a stabilization pressure of 35 bars and a sample concentration of 1.5 mg ml-1. 
A Waters Styragel HT column for midrange molecular-mass distributions was used, and 
samples of polystyrene with different molecular masses were used as standard. The 
chemical structure of both polymers and monomer composition of PHBV were 
determined by Proton Nuclear Magnetic Resonance (1H NMR)[20]. Spectra were 
recorded at 25°C on a Bruker AM300 spectrometer. The polymer samples were dissolved 
in chloroform and a drop of TMS (tetra methyl silane used as internal standard for 
calibrating chemical shift for 1H) was added as reference. 10 mg of the sample dissolved 
in 1 ml of deutered solvent was used. Proton spectra were recorded at 300.1 MHz with a 
spectrum of 32 K data points. A total of 64 scans were utilized with a relaxation delay of 
1 s. 
2.3. Surface treatment procedures 
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Mirror-like, smooth surfaces were achieved by grinding with SiC papers of decreasing 
grit size (from P800 to P2400–European P-grade standard), followed by polishing with 
suspensions of alumina particles on cotton cloths containing hydrogen peroxide (6 µm 
and 1 µm particle size). Prior to chemical activation, samples were ultrasonically rinsed 
with cyclohexane, isopropanol, distilled water, ethanol and acetone. Samples were stored 
dry under a vacuum. Oxygen plasma technique (Plasma): Surface cleaning and 
activation were carried out by means of plasma cleaning (Plasma Cleaner, Sterilizer 
PDC-002, Harrick Scientific Corporation, USA). After oxygen purging and high vacuum 
(3 times) the samples were exposed at low electromagnetic radiofrequency radiation 
(between 8 and 12 MHz) for 10 min. Sodium hydroxide treatment (NaOH): The Ti 
disks were immersed in 5 M of previously prepared NaOH in closed polypropylene 
flasks. They were placed into a furnace at 60 ºC for 24 h. Afterwards the samples were 
cleaned and immersed in Milli-Q water for 30 min, then rinsed with water of the same 
quality and acetone. They were dried with nitrogen and, finally, stocked in a vacuum. 
2.4. Drug/ biopolymer matrix preparation  
Gentamicin dispersion on biopolymer solution: Gentamicin sulfate particles were 
incorporated in 10% and 30% (w/w) of the biopolymer mass to a saturated solution of 
biopolymer in chloroform under conditions of constant stirring. Emulsion Preparation 
(Water in oil (W/O) emulsion technique): The used method was based up on that 
reported by Chen and Davis [21] and further modification by Rodríguez-Contreras et. 
al [12,13]. Simple emulsion was carried out by PHB solving in chloroform (10 mL) 
(organic phase). Then, 2 mL of aqueous solution of Genta with 2% PVA was emulsified 
into the previous organic solution under ultrasonic homogenizer at 5W (3 min at 60%) 
(Bandelin Sonopuls with microtip MS 73). Different concentrations of Genta (10% and 
30% (w/w) of the polymer mass) and polymer (5, 10, 20 and 40 mg/mL) were studied.  
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2.5.  Dip-Coating process 
The previously described solut ions (gentamicin dispersion and daily fresh 
prepared W/O emulsion) were used to coat Ti surfaces by dip-coating technique. 
KSV NIMA Dip Coater (Nima instruments, Stockholm, Sweden) was used with a single 
vessel and KSV NIMA Dip Coaters software. The substrate was immersed with a 
constant rate of 10 mm/min and it was extracted with a controlled output rate of 70 
mm/min. The process was performed at room temperature (22 ºC). Different numbers of 
immersions were studied (1, 3 and 6 times dip-coating), being assured that each coating 
was totally dried between every immersion. Different combinations of immersions were 
also tested, with a range of concentrations of gentamicin sulfate in each immersion. 
Figure 1 shows a summary scheme of the PHAs coating on titanium surface. 
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Figure 1. 
2.6. Physicochemical characterization 
Wettability and contact angle (CA): Static contact angles were measured with water 
and biopolymer solution respectively using the sessile drop method (Contact Angle 
System OCA15 Plus; Dataphysics, Germany). Measurements were acquired in triplicate 
for three samples at room temperature, with a volume of 3 µL and a dose of 1 µL /s. 
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Biopolymers solutions (40 mg/mL in Chloroform for the highest polymer 
concentration) were prepared to study their wettability and affinity to the Ti-activated 
surfaces. Field Emission Scanning Electron Microscope (FESEM): Scanning electron 
micrographs were obtained using a Jeol (JSM-7001F, Japan) scanning electron 
microscope, operating at 20 KV. Energy Dispersive X-ray Spectroscopy (EDS) was 
also used for the elemental analysis of the surfaces. Roughness analysis: White light 
interferometry (Wyko NT1100 Optical Profiler, Veeco Instruments, USA) was used to 
evaluate roughness of the samples. The average height (Ra) of each sample was 
measured in three randomly chosen points of the disk. Finally, sample thickness was 
measured by perfilometry (Veeco, Dektak 150). 
2.7. Drug delivery characterization  
Release of gentamicin sulphate from the coated Ti surfaces was evaluated. In vitro 
release profiles were obtained by immersing coated samples in 10 mL phosphate buffer 
solution (PBS) (pH 7.40) under conditions of mild stirring. The vials were incubated at 
37 ºC. At predetermined intervals, 1 mL of release media was taken to assay drug 
concentration, while a fresh PBS replaced the same volume [22]. In order to 
determine the amount of released drug, mass spectroscopy was used (Varian 500-MS) 
using a Zorbax Eclipse XVB-C18 column (4,6x150 mm, 5µm, 80Å). This evaluation 
was performed three times per sample. 
2.8. Biological characterization  
Human osteoblast-like Saos-2 cells were cultured in McCoy’s 5A medium (Sigma-
Aldrich) supplemented with 10% fetal bovine serum (FBS), penicillin/streptomycin (50 
U/mL and 50 µg/mL, respectively), 2 mM L-glutamine, 1 mM sodium pyruvate and 20 
mM HEPES buffer at 37 ºC in a humidified atmosphere at 5% CO2, all from Invitrogen. 
Cells were harvested at confluence using TrypLE (Invitrogen) and seeded at a cell 
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density of 1 × 104 cells/well. Cell citotoxicity assay: Indirect in vitro cytotoxicity tests of 
the treated surfaces of Saos-2 cells were carried out by analyzing the activity of the 
lactate dehydrogenase (LDH) enzyme by the Cytotoxicity Detection Kit LDH. Each 
specimen was immersed in DMEM for 72 h at 37 ± 2 °C with an extraction medium 
area/volume ratio of 0.5 cm
2
/1 mL (according to ISO 10993-5). Afterward, the 
extraction medium was removed and diluted with DMEM (dilution 1/0; 1/1; 1/10; 1/100; 
1/1000). As a reference for 100% maximum survival, cells were placed in TCPS (Tissue 
culture polystyrene).
 
In vitro antibacterial assay: A commonly used procedure for 
studying the antibacterial action was followed [23,24]. The assay was performed with 
both Gram-positive and Gram-negative bacteria (Staphylococcus aureus and 
Escherichia coli, respectively). The overnight-incubated bacteria solutions were diluted 
with sterile PBS solution until it reached an absorbance value of 0.2 at 600 nm (bacterial 
concentration about 10
8 
CFU/ml). The solutions were used to inoculate (100 µL) on Petri 
plates with Chromocult® (Merck) media for E. coli and Triptoy Soy Agar (TSA) media 
for S. aureus. The discs were placed in the middle of the inoculated surface. The plates 
were incubated at 37 ºC for 24 hours, when the diameter of inhibition was measured. 
The controls were carried out with drug-free disks. Cell adhesion assay: SAOS P31-
Sarcoma Osteogenic cells were seeded onto titanium samples, which had been 
previously sterilized with ethanol (70%, v/v), at a density of 20,000 cells/disk and 
incubated at 37 °C and 5% (v/v) CO2 containing atmosphere. 4 h post-seeding non-
adherent cells were washed off by gently rinsing with PBS, and remaining cells were 
lysed with 200 µl/well of M-PER® (Pierce, Rockford, IL, USA). Enzymatic activity of 
lactate dehydrogenase(LDH) was quantified by colorimetric assay (Cytotoxicity Detec-
tion Kit (LDH), Roche Diagnostics, Mannheim, Germany), using amultimode microplate 
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reader (Infinite M200 PRO, Tecan GroupLtd., Männedorf, Switzerland). Cell number 
was obtained using a standard curve. 
2.9. Statistical studies 
Surface characterization and biological results were expressed as a mean value of 
standard deviation (SD) for each sample. T-test was used with a 95% confidence interval 
to evaluate statistical differences.  
 
3. RESULTS AND DISCUSSION 
In order to obtain surfaces with antibacterial activity, coatings of PHAs loaded with Genta as 
an antibiotic were used to cover Ti surfaces. There has been an increasing interest in the use 
of natural materials as drug delivery vehicles due to their appealing properties. The natural 
origin, biodegradability, and biocompatibility of PHAs make them suitable for a variety of 
applications in the health industry [10,25,26]. Particularly because of their property of 
biodegradation, PHAs were studied as a matrix for the antibiotic and as a controlled drug 
delivery system.  
3.1. Biopolymer characterization 
 
The biopolymer molecular masses were analyzed by GPC and the results show similar 
MW for both biopolyesters: 240 kDa for PHB and 270 kDa for PHBV with 
polydispersity index (PDIs) of 8.6 and 3.4, respectively (figure 2 C and D). H1 NMR 
was carried out to verify the biopolymers structure (figure 2 A and B).  The 
characteristic peaks at 0.99 ppm and 1.25 ppm for methyl group for valerate and 
hydroxybutyrate monomers, respectively, can be used to determine the valeric 
composition in the copolymer PHBV sample according to equation 1 [27,28]: 
                           
              
                            
      [1] 
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It was confirmed that PHBV has 19 mol% of the monomer HV. The presence of this 
monomer decreases the polymer crystallinity and, thus, its mechanical properties change 
(high elastic modulus and flexural strength with low tensile strength and elongation at break) 
[29] and degradability [30]. Such different properties directly influence the features of the 
coatings with both polymers.  
 
Figure 2. 
3.2 Ti activation technique characterization 
 
Oxygen plasma and NaOH treatments were used to modify Ti surfaces. Both methods 
allow modification of surfaces by attachment or adsorption of functional groups to tailor 
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surface properties for specific applications. In particular, both methods chemically 
remove organic contaminants and promote surface oxidation and hydroxylation (OH 
groups) by increasing surface wettability [31]. Especially, chemical treatment in alkali 
solutions is a strong contender to impart submicron or nano-roughness to Ti surfaces 
[32,33,34]. NaOH treatment generates a homogeneous roughness on Ti surface with a 
very intricate and nano-porous morphology, whereas plasma cleaning did not modify the 
surface roughness (compare figure 3 B and C). The corresponding profile roughness 
parameter Ra has been included on the micrographs. Biopolymers solutions (PHB and 
PHVB) were prepared to study their wettability and affinity to the activated Ti surfaces. 
The contact angles of both biopolymer solutions are significantly lower on the Ti surface 
treated with NaOH (figure 3D). This improvement of surface affinity to the biopolymer 
solutions is explained due to the incorporation of higher OH groups on the Ti surfaces, 
which allow the bounding with the carboxylic groups at the end of the biopolymers 
chain via Van der Waals bounds. This affinity is greater with PHB, probably due to its 
lower MW and higher PDI than PHBV. This lower MW and higher PDI leads to a 
greater number of shorter polymer chains. Therefore, PHB shows a greater number of 
ending groups, carboxylic group, which easily bond with OH groups, than PHBV. 
According to the literature, NaOH etching is the most efficient activation method for 
promoting surface hydroxylation (incorporation of OH groups) increasing its surface 
wettability and its specific area. Higher roughness and consequently more specific 
surface for samples chemically treated, probably, benefit the physical absorption of the 
biopolymer solutions. Therefore, chemical activation with NaOH solution was the 
activation method selected for further studies. 
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Figure 3. 
3.3. Emulsion preparation 
Since gentamicin is not soluble in the same solvents as PHB and PHBV, a dispersion of 
the particles in the biopolymers solution was prepared and used in a first attend to further 
cover the Ti surface by dip-coating. Unfortunately, a homogeneous distribution of 
gentamicin particles dispersed in the polymer coating was not achieved; Genta particles 
were in most cases too big and they tended to cluster. Figure 4 shows Ti surface after 
dip-coating with Genta dispersed in PHB/chloroform solution. In order to obtain an 
optimal homogeneity of the antibiotic in the biopolymer matrix, emulsions of the drug in the 
biopolymer solution were proposed as fluids for the process of surface covering via dip-
coating. Following previous reported studies for PHA emulsion preparation [13], an 
aqueous solution of Genta with 2% PVA was emulsified into the organic solution 
(biopolymer in chloroform) using an ultrasonic homogenizer. The strategy of using water 
in oil (W/O) emulsions as a fluid for dip-coating technique was appropriate to obtain 
uniform distributions of gentamicin sulfate in the coating. 
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Figure 4. 
3.4. Dip-Coating process 
Different biopolymer concentrations and numbers of dip-coating (1, 3 and 6 immersions) 
were tested to study the covering of the Ti surfaces (figures 5). More homogeneous 
coatings were obtained with the higher concentration of biopolymer (40 mg/mL) in the 
emulsions. Therefore, all subsequent studies of Ti surface coating were carried out with 
this concentration. Regarding the number of dip-coatings, the surfaces were entirely 
covered by the biopolymers after 6 immersions; confirmed by FESEM images (figure 5 
c and f). Both biopolymer coatings show very different topographies. PHBV forms 
highly porous surfaces (average of pores diameter around 50 µm), while PHB shows more 
compact, thicker and heavier ones (figures 5 G and H). Figures 5f and 5c show FESEM 
images at high magnification, where it can be confirmed that the biopolymer coating 
totally covers the Ti surfaces. Regarding PHBV coatings, a porous network is being 
added in each immersion, thus increasing the roughness and the volume of the coating 
with the number of immersions (figure 5G). This porous structure will promote drug 
release, since it shows higher specific surface, exposing the biopolymer to a higher 
degradation. These porosities or cavities could also provide for space for the cells to 
grow among the coating, thus improving their biointegration. The amount of Genta in the 
emulsion did not modify this results. The water contact angle was measured on the PHB 
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and PHBV coating surfaces. They normally show high contact angles of 60-90 degrees 
[36]. However, a drop of water was immediately absorbed by the substrate, possibly due 
to the topography of the surfaces. 
 
Figure 5. 
3.5. Toxicity assay and cell adhesion 
The conditions studied were the ones exhibiting great risk of toxicity; coatings with six 
times the process of dip-coatings and 30% gentamicin sulfate, since the antibiotic content 
is the highest. Figure 6 shows the results of the toxicity test. According to UNE-EN ISO 
10993-5, the percentage of cell survival should exceed 80% in the first dilutions to 
ensure that the system is not toxic. In the case of the study, all samples tested have 
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exceeded this percentage and, consequently it can be confirmed that the proposed 
systems are not toxic. Furthermore, the non-toxicity of the biopolymer coatings was 
confirmed by the results from cell adhesion test. Osteoblastic cells adhered to PHB and 
PHBV coatings in the same number as polished Ti surfaces (results show no significant 
differences between samples and Ti surfaces) (data not shown).     
 
Figure 6. 
3.6 Drug delivery studies 
 
The technique of delivery must guarantee a rapid release of the antibiotic from the 
carrier, and local drug levels above the minimal inhibitory concentration (MIC). For 
gentamicin, these limits are: MIC50=0.5 µg/mL and MIC90=32.0 µg/mL [37]. Genta 
release profiles from PHB and PHBV coatings of 3 and 6 immersions are shown in 
figure 7A. In terms of initial drug release and release rate, there are no remarkable 
differences between coatings made with 3 or 6 immersions. As expected, lower amount 
of drug is released when the number of dip-coating is less, since there is fewer antibiotic 
incorporated to the bulk of the polymer matrix. The release profiles show a fast liberation 
of gentamicin the first 24 hours of incubation, afterward drug release rate decreases, and 
it is maintained until the end of the incubation. According to these experimental results, 
release of the active principle from the biopolymer matrix takes place in two stages. In 
the early hours of incubation, gentamicin is released from the surface of the coating. 
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Once the external gentamicin is totally released, then the polymer matrix must be 
degraded to liberate the remaining active principle inside the bulk. Comparing both PHAs, 
the initial drug released from PHB coatings is higher than from PHBV ones, regardless of the 
number of immersions. While having the same number of dip-coatings and the same drug 
concentration, PHB samples incorporate more active principle than PHBV. This can be 
corroborated by the coating weight, which is higher for the PHB coatings (figure 5H), and it 
can be related to the chemical or physical interaction between the drug and the biopolymer. 
PHB has lower MW and higher PDI than PHBV, consequently it shows a higher number of 
carboxyl groups placed at the end of the biopolymer chains. This chemical group can easily 
bond with the hydroxyl and amine groups from gentamicin, giving to PHB coatings more 
affinity to the active principle.  
In the second stage of drug release, PHB samples do not reach the minimum inhibitory 
concentrations (MIC50 = 0.0005 mg/mL) required for antimicrobial properties in some 
cases, while samples with PHBV show drug release above MIC limit in all cases. This 
can be explained by two reasons. First, the better affinity (and linkage) that PHB exhibits 
for gentamicin sulfate compared to PHBV, prevents it from being readily released. 
PHBV can more easily loosen its chemical bonds with gentamicin, thus, releasing it 
easily. The second reason is related with the different degradation rates of both 
biopolymers, since the polymer matrix has to be degraded in order to release the drug 
located inside the coating. PHBV has shown faster degradation than PHB due to its 
lower crystallinity [38]. It is reported that when stored at 37°C for 6 months in human 
blood serum PHB degrades very slowly with a weight loss of 5% [39]. Moreover, the 
high porosity that PHBV shows affects its degradation process, and, consequently, the 
drug delivery. This has been confirmed by studying the stability of biopolymer coatings. 
After two weeks of incubation under physiological conditions (PBS and 37°C) the initial 
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morphology of biopolymer coating surfaces changed, revealing early signs of 
degradation (Figure 7B). Holes can be observed on the surfaces of PHB coating after 
their exposure to PBS for two weeks, while smooth surfaces can be detected on initial 
coatings (figure 5C). The more rapid rate of degradation of PHBV with respect to PHB 
can be inferred from both the range of holes sizes and the roughness of the surface of the 
highly porous network of PHBV coatings (Figure 7B, PHBV inset). Given the drug 
profile of PHBV, and, in consideration of the results described above it can be confirmed 
that confirmed that PHBV coatings allow the release of enough quantity of drug (above 
MIC value) to maintain antimicrobial properties for longer periods of time. 
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Figure 7. 
 
3.7. Drug delivery studies of PHAs coatings with combined % of Genta per Dip-
Coating 
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An advantage of dip-coating process is that it allows the combination of different layers 
of polymers and active principle amounts. Thus, a variety of dip-coatings with a range of 
gentamicin concentrations were studied in order to prevent the quick first release of 
active principle and to acquire drug release profiles more homogeneous and constant 
with PHBV. In all cases, the amount of gentamicin in the outer layer was 10% in order to 
control the burst release of drug at short times of incubation. When 6 dip-coatings were 
applied, the release rate of gentamicin sulfate considerably decreased (by 78%) in the 
first hours of incubation compared to the release rate of the samples which have uniform 
amount of gentamicin (Figure 8). However, this decrease of the drug release rate for 
coatings with 3 dip-coatings is less (6% slower for coatings with alternating 
concentrations of gentamicin). After the first hours of incubation, the amount of drug 
released continues to be above the MIC for 20 days, showing a more consistent release 
profile than the samples with the same concentration of gentamicin in all layers. Thus, it 
was possible to attain a more stable and homogeneous drug release for the period of time 
studied, and, in particular, after the first hours of incubation.  
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Figure 8. 
3.8. In vitro antibacterial assay 
Determination of bacterial growth inhibition was performed with both Gram-positive and 
Gram-negative bacteria (Staphylococcus aureus and Escherichia coli, respectively). All cases 
tested (PHBV coatings with 1, 3 and 6 immersions and with 10 and 30% Genta) show growth 
inhibition of both microorganisms, indicating that Genta released is above 0.0005 mg/mL, 
according to the literature [37]. There was a slight increase in the diameter of the inhibitory 
growth zone when the concentration of Genta was higher and also when the number of dip-
coatings increased. The diameter of the halo is then proportional to the percentage of drug 
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concentration, and the number of immersions. The effect of the antibiotic on both bacteria is 
very similar (without significant differences), although gentamicin is reported to have a 
stronger effect on Gram-negatives such an E. coli [40]. Ti discs with PHBV coating with 
different dip-coatings (3 and 6) and with both, simple (30%) (figure 9A) and combined 
(10-30%) (figure 9B) Genta concentration per layer, were tested after drug release 
analyses to confirm their antibacterial properties. After 24, 264 and 480 hours of 
incubation in physiological conditions at 37 
O
C, samples show different sizes of the inhibition 
zone diameter (figure 9C). In particular after 20 days (480 h) of incubation, the coatings 
provide Ti surfaces with a significant antibacterial effect (compare the diameter of the 
inhibition zone of the samples with the controls: Ti surfaces without coating and with 
biopolymer coating without Genta) after drug release through the period of time studied. 
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Figure 9. 
4. Conclusions  
A drug delivery system for an application involving gentamicin was developed in this study 
by using a dip-coating technique to achieve an optimum coating on Titanium surfaces using 
biodegradable biopolymers, PHB and PHBV. The dip-coating technique makes it possible to 
combine layers with varying drug concentrations in order to obtain distinct coatings with a 
range of drug release profiles. In this study, the optimal conditions for applying dip-coating 
technique for obtaining an optimal drug delivery were achieved. The optimal release profiles 
obtained exceeded, for all intervals of time tested, the minimum concentration for the 
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antibiotic to be effective, without surpassing the limits of toxicity. The system designed for 
drug delivery not only assures the elimination of the first stage of bacterial biofilm formation 
(bacterial adhesion), but also their proliferation, since the biopolymer coating with antibiotic 
is able to degrade with time under physiological conditions guaranteeing a controlled drug 
release. Specifically, the use of PHBV for the coating of Ti surfaces with different active 
principle concentration layers, results in a more constant and homogeneous drug release.  
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Figure Legends: 
Figure 1. Scheme of the process of Dip-Coating. 
Figure 2. H
1
 NMR of homopolymer PHB spectra (A): a doublet at 1,274 ppm attributed 
to the methyl group (-CH3) coupled with one proton (signal 3), a doublet of quadruplet at 
2.520 ppm which is attributed to a methylene group (-CH2) adjacent to an asymmetric 
carbon atom bearing a single proton (signal 2), and a multiplet at 5.260 ppm 
characteristic of the methane group (-CH) (signals 1). H
1
 NMR of copolymer PHBV (B): 
the presence of valerate monomer incorporates the signals 4, 5 and 6, attributed to the 
methyl group (-CH3) at 0.99 ppm, a methylene (-CH2) resonance at 1.6 ppm and methyne (-
CH) resonance at 5.260 ppm, respectively. GPC spectra of PHB (C) and PHBV (D). 
Figure 3. Ti surface characterization: FESEM micrograph and surface roughness of Ti 
surface polished (A), after Plasma treatment (B) and after treatment with NaOH (C). 
Scale bars correspond to 600 nm. Contact angle of PHB and PHBV solutions on the 
different Ti surfaces. There are significant differences between the contact angle form 
with non-treated PHB solution on Ti surfaces and oxygen plasma treated with NaOH. *p 
< 0.05: statistically significant (D). 
Figure 4. FESEM images of gentamicin sulfate spheres. Average of particle size 
correspond to (45,70 ± 23,24) μm with a normal distribution. Scale bars correspond to 40 
m (A). Non-homogeneous Genta spheres deposition on Ti surfaces with PHB as drug 
carrier. Scale bars correspond to 500 m (A). 
Figure 5. Characterization of biopolymer coatings. FESEM images of biopolymer 
coatings with different immersions: (A) PHB partial coating with 1 immersion, (B) PHB 
partial coating with 3 immersion and (C) PHB total coating with 6 immersion, (D) 
PHBV partial coating with 1 immersion, (E) PHBV partial coating with 3 immersion and 
(F) PHBV total coating with 6 immersion.  Scale bars correspond to 300 m. (c, f) 
FESEM images of totally covered coatings of PHB and PHBV at higher magnifications.  
Scale bars correspond to 40 m. (G) Values of roughness and thickness of the coatings. 
(H) PHB and PHBV coating with 3 and 6 immersions. *p < 0.05: statistically significant. 
Figure 6. Cytotoxicity results (UNE-EN ISO 10993-5) 
Figure 7. Drug release of PHB and PHBV coatings of different immersions. Main 
graphics show gentamicin accumulated release with time, while the graphic insets show 
the quantity of gentamicin released in every time (A). FESEM micrograph’s of PHB 
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(left) and PHBV (right) coatings (6D with 30% Genta) after 2 weeks in PHS and 37 
o
C. 
Scale bars correspond to 300 m and the one in the inset 40 m. 
Figure 8. Comparison of drug release profiles of PHBV coatings between 30% Genta 
amount in all layers, and coatings with alternating concentrations of gentamicin per 
immersion. The primary graphics show gentamicin accumulated release over time, while 
the graphic insets show the quantity of gentamicin released in every mesurement. 
Figure 9. Diameter of halo of inhibition growth of E. coli and S. aureus of PHBV samples 
with 3 (3D) and 6 (6D) dip-coating, combined (10-30%) (A) and with simple (30% Genta) 
(B) gentamicin concentration. Controls: Ti surfaces without coating and Ti surfaces with 
PHBV coating without Genta did not show any halo of inhibition growth.  (C) Image of the 
petri plates showing the halos of inhibition growth for E. coli after 1 day, 11 days and 20 days 
of incubation of Ti surfaces coated with PHBV (3 immersions and 30% Genta in all 
coatings). 
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Highlights:  
1. Optimum coating on Ti surfaces with PHB and PHBV for drug delivery 
2. Different dip-coatings layers offer different drug release profiles 
3. The designed biopolymer systems prevent the bacterial attachment 
 
 
